Marvell Technology, Inc. quarterly report, Q2 FY2023

Marvell Technology, Inc. — Form 10-Q Summary

Reporting period: Second quarter and first six months of fiscal 2023, ended July 30, 2022; comparisons are to the corresponding periods ended July 31, 2021. Amounts are in U.S. dollars unless noted. The financial statements are unaudited.

Financial performance

MetricQ2 FY2023Q2 FY2022Six months FY2023Six months FY2022
Revenue$1,516.9 million$1,075.9 million$2,963.8 million$1,908.2 million
Gross profit$786.0 million$371.8 million$1,536.9 million$790.0 million
Gross margin51.8%34.6%51.9%41.4%
Operating income (loss)$39.1 million$(266.7) million$108.9 million$(349.0) million
Net income (loss)$4.3 million$(276.4) million$(161.4) million$(364.6) million
Diluted EPS$0.01$(0.34)$(0.19)$(0.48)
Operating cash flowNot separately presented for the quarter$526.3 million$208.4 million

Q2 revenue increased 41% year over year; six-month revenue increased 55.3%. Management attributed growth primarily to higher demand and unit shipments, with higher average selling prices reflecting a richer mix of products with more content and features. Six-month growth also benefited from the prior-year acquisitions of Inphi and Innovium. Gross margin improved substantially, which management primarily attributed to lower amortization of acquisition-related inventory fair-value adjustments.

Q2 R&D expense was $449.0 million, up 22.3%, primarily from higher personnel costs and acquisition-related headcount. Q2 SG&A fell 18.3% to $211.7 million, mainly because of lower Inphi integration costs and amortization of fully amortized intangibles. Results included a $100.0 million legal settlement charge for the six-month period, of which $85.0 million was recorded in Q2.

Cash, debt, and liquidity

  • Cash and cash equivalents were $617.1 million at July 30, 2022, versus $613.5 million at fiscal year-end. Approximately $431.3 million was held by foreign subsidiaries.
  • Six-month operating cash flow was $526.3 million. Working capital used approximately $503.0 million, including increases in receivables, inventory, and supply-capacity prepayments. Investing activities used $212.3 million, including $109.5 million of property and equipment purchases and $98.6 million for acquisitions, net of cash acquired.
  • Debt carrying value was $4.601 billion, including $653.5 million classified as current. Face-value borrowings were $4.636 billion. The company had $70.0 million drawn on its $750.0 million revolving facility, leaving $680.0 million undrawn; management intended to repay the drawn amount in fiscal Q3.
  • Management said cash, operating cash generation, and available revolving-credit capacity should cover working capital, capital expenditures, investments, dividends, repurchases, and commitments for at least the next 12 months. The company reported compliance with debt covenants.
  • Inventory increased to $913.1 million from $720.3 million at fiscal year-end; accounts receivable increased to $1.291 billion from $1.049 billion.

Material changes and unusual items

  • The six-month net loss included a $213.6 million deferred tax expense from remeasurement of Singapore deferred tax assets following a five-year extension of the Singapore tax incentive through June 30, 2029. The six-month tax provision was $204.4 million despite a pretax profit of $43.0 million.
  • After quarter-end, Marvell reached an agreement in principle to resolve a customer contractual dispute for $100.0 million in cash over several quarters. It had previously reserved $15.0 million and accrued a further $85.0 million in Q2.
  • Marvell resumed share repurchases in fiscal 2023. It repurchased 1.2 million shares for $65.0 million in the first six months and paid $102.0 million in dividends. Repurchase authorization remaining was $499.5 million.
  • Goodwill was $11.579 billion and acquired intangible assets were $5.643 billion at quarter-end, reflecting significant acquisition-related balances and future impairment exposure.

Outlook, management commentary, and risks

Marvell provided no specific numeric revenue or earnings guidance in the supplied filing text. Management reported strong customer demand but said industry-wide supply constraints were limiting its ability to meet demand for some complex infrastructure products. It expected semiconductor supply constraints to continue through fiscal 2023 and described securing production capacity as a priority, while noting associated input-cost increases and efforts to adjust customer pricing.

Capacity reservation arrangements support supply but create significant commitments: the company estimated at least $2.7 billion of purchase-level commitments for wafers and other manufacturing products from the remainder of fiscal 2023 through fiscal 2033. Unconditional commitments at quarter-end included $3.439 billion to foundries and test-and-assembly partners and $612.5 million in technology license fees.

Management expects U.S. export restrictions on certain Chinese customers to continue affecting fiscal 2023 revenue. Other key risks include customer order cancellations or inventory changes, customer and distributor concentration, reliance on manufacturing partners concentrated in Asia, COVID-related disruptions, inflation and rising interest rates, acquisition integration, debt obligations, and legal and tax uncertainties. A 1-percentage-point change in interest rates would change annual interest expense by approximately $15.3 million.

Most important facts for investors to verify

  • Whether growth and margin gains persist after accounting for acquisition effects, product mix, and reduced acquisition inventory amortization.
  • Whether supply constraints ease, capacity commitments convert into deliverable supply, and associated costs can be offset through pricing.
  • The timing and cash impact of the $100.0 million customer settlement and other legal matters.
  • The drivers and potential recurrence of tax expense, especially the Singapore deferred-tax remeasurement and conditions attached to the tax incentive.
  • Debt maturities, variable-rate exposure, working-capital needs, and the company’s capacity to fund substantial manufacturing commitments while returning capital to shareholders.
  • Exposure to China-related export controls and geographic and customer concentration; one distributor represented 24% of Q2 revenue, and four customers accounted for 56% of gross receivables.